Biocell · 2023 · 33 citations · 99 references
Life SciencesImmunologyPharmacologyCell SignalingInflammationInnate ImmunityGastrointestinal InflammationGut MicrobiotaInflammatory Bowel DiseaseInflammatory Response RegulationInflammatory SignalingMucosal InflammationAnimal Disease ModelsChemotaxisClinical RemissionInflammatory Bowel Disease PathogenesisInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease TherapyIntestinal Microbiota EffectsIntestinal Microbiota Modulation
Curcumin, a natural product, has exhibited promising effects in both animal models and clinical trials, interacting with a multitude of factors linked to Inflammatory Bowel Disease (IBD). These factors encompass cytokines, oxidative stress-associated enzymes, and modulation of the intestinal microbiota. Notably, curcumin has demonstrated therapeutic potential in animal models of colitis, wherein it exerts a negative regulatory influence on pivotal signaling pathways such as PI3/Akt, JAK/STAT, and β-catenin. Moreover, it inhibits the expression of pro-inflammatory enzymes and co-stimulatory molecules (including RANKL, ICAM-1, CD205, CD256, TLR4, among others), while curbing immune cell chemotaxis, thereby attenuating the characteristic neutrophil infiltration observed in IBD. Another facet of curcumin’s action involves its modulation of the intestinal microbiota. Notably, the microbiota itself contributes to beneficial biotrans formations of curcumin, thereby enhancing its effectiveness in IBD treatment. On a clinical front, curcumin has demonstrated the ability to induce clinical and/or endoscopic remission without any reported toxic effects. Hence, curcumin warrants consideration as an adjunctive therapy in IBD management. Subsequent clinical investigations should concentrate on meticulously evaluating curcumin’s impact on these precise therapeutic targets.
99
Chander Shekhar, Monaghan Pj, Jane Morris et al. · IRIS Research product catalog (Sapienza University of Rome) · 2013 · 2.7K citations
Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations
Medicine, Oncology, Pharmacology +10
Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers
Guido Shoba, David C. Joy, Thangam Joseph et al. · Planta Medica · 1998 · 1.9K citations
Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
Wai‐Ki Ip, Namiko Hoshi, Dror S. Shouval et al. · Science · 2017 · 1.4K citations · Full text